Catalyst
Slingshot members are tracking this event:
Editas Medicine (EDIT) to initiate natural history trial LCA10, a vaccine for eye disease, in the middle of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EDIT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 09, 2017
Occurred Source:
http://ir.editasmedicine.com/phoenix.zhtml?c=254265&p=irol-newsArticle&ID=2293050
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Eye Disease, Clinical Natural History, Lca10
